The transforming growth factor-βs: Structure, signaling, and roles in nervous system development and functions

Journal of Neurochemistry

Volumn 75, Issue 6, 2000, Pages 2227-2240

  Böttner, Martina ^a   Krieglstein, Kerstin ^a   Unsicker, Klaus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cell lineage; Glia differentiation; Growth factors; Neuron death; Repair

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

GLIA; HUMAN; MACROGLIA; MAMMAL; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; HUMANS; MORPHOGENESIS; MULTIGENE FAMILY; NERVOUS SYSTEM; NEUROGLIA; NEURONS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

MAMMALIA;

EID: 0033773180     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0752227.x     Document Type: Review

References (176)

1. Transforming growth factor-beta 1 promotes re-elongation of injured axons of cultured rat hippocampal neurons
2. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice
3. Transforming growth factor beta 1: Secondary structure as determined by heteronuclear magnetic resonance spectroscopy
4. Activation of signalling by the activin receptor complex
5. Effects of transforming growth factor-β1 on the extracellular matrix and cytoskeleton of cultured astrocytes
6. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex
7. Transforming growth factor-beta 1 inhibits inflammatory cytokine-induced C3 gene expression in astrocytes
8. Differential modulation of astrocyte cytokine gene expression by TGF-beta
9. Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10
10. Source of the anti-Mullerian hormone synthesized by the fetal testis: Mullerian-inhibiting activity of fetal bovine Sertoli cells in tissue culture
11. Expression of TGF-β type II receptor mRNA in the CNS
12. Cranial neural crest cells synthesize and secrete a latent form of transforming growth factor beta that can be activated by neural crest cell proteolysis
13. Evolution of the transforming growth factor-beta superfamily
14. Evolutionary origins of the transforming growth factor-beta gene family
15. + channels by target-derived TGF beta in vivo and in vitro
16. + currents by target-derived factors: Opposing actions of two different isoforms of TGFbeta
17. Extracellular modulation of the Hedgehog, Wnt and TGF-beta signalling pathways during embryonic development
18. Transforming growth factor beta has neurotrophic actions on sensory neurons in vitro and synergistic with nerve growth factor
19. Tumor necrosis factor-alpha mediates the release of bioactive transforming growth factor-beta in murine microglial cell cultures
20. Tumor necrosis factor-alpha production by human fetal microglial cells: Regulation by other cytokines
21. Modulation of human microglial cell superoxide production by cytokines
22. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells
23. Smad4 and FAST-1 in the assembly of activin-responsive factor
24. Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins
25. Pioneer axon guidance by UNC-129, a C. elegans TGF-beta
26. Reduction of endogenous TGF-beta increases proliferation of developing adrenal chromaffin cells in vivo
27. 2 by postnatal cerebellar neurons and its effect on neuroblast proliferation
28. Transforming growth factor beta 1 (TGF-β1) expression and regulation in rat cortical astrocytes
29. Glial cell-specific mechanisms of TGF-β1 induction by IL-1 in cerebral cortex
30. Crystal structure of transforming growth factor-beta 2: An unusual fold for the superfamily
31. A new type of transforming growth factor-beta, TGF-beta 3
32. GDNF signalling through the Ret receptor tyrosine kinase
33. Bone morphogenetic proteins and their receptors: Potential functions in the brain
34. Molecular profile of reactive astrocytes - Implications for their role in neurologic disease
35. Purification and characterization of erythroid differentiation factor (EDF) isolated from human leukemia cell line THP-1
36. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-beta-induced transcriptional activation
37. Decapentaplegic acts as a morphogen to organize dorsal-ventral pattern in the Drosophila embryo
38. TGF-β1 is an organizer of responses to neurodegeneration
39. Analysis of mice carrying targeted mutations of the glucocorticoid receptor gene argues against an essential role of glucocorticoid signalling for generating adrenal chromaffin cells system
40. Localization and actions of transforming growth factor-βs in the embryonic nervous system
41. Effect of TGF-βs and bFGF on astroglial cell growth and gene expression in vitro
42. Altered expression of transforming growth factor-beta in Alzheimer's disease
43. Transforming growth factor-βs in neurodegenerative disease
44. Cytokine-induced changes in the ability of astrocytes to support migration of oligodendrocyte precursors and axon growth
45. The GS domain of the transforming growth factor-beta is important in signal transduction
46. Rapid TGF beta 1 effects on actin cytoskeleton of astrocytes: Comparison with other factors and implications for cell motility
47. Regulation of the transmitter phenotype of rostral and caudal groups of cultured serotonergic raphe neurons
48. Developmental regulation of the serotonergic transmitter phenotype in rostral and caudal raphe neurons by transforming growth factor-betas
49. Transforming growth factor-beta 3, glial cell line derived neurotrophic factor, and fibroblast growth factor-2 act in different manners to promote motoneuron survival in vitro
50. Serotonin 5-HT2A receptor induces TGF-beta1 expression in mesangial cells via ERK: Proliferative and fibrotic signals
51. Three-dimensional structure of recombinant human osteogenic protein 1: Structural paradigm for the transforming growth factor β superfamily
52. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
53. Central nervous system neuronal migration
54. TGF-beta signalling from cell membrane to nucleus through SMAD proteins
55. The Smads
56. Transforming growth factor beta 1: Three-dimensional structure in solution and comparison with the x-ray structure of transforming growth factor beta 2
57. Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination
58. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development
59. MADRI, a MAD-related protein that functions in BMP2 signaling pathways
60. Role of growth factors in catecholaminergic expression by neural crest cells: In vitro effects of transforming growth factor beta 1
61. Cytokine modulation of murine microglial cell superoxide production
62. Transforming growth factor-βs inhibit mitogen-stimulated proliferation of astrocytes
63. Tumor necrosis factor alpha induces adhesion molecule expression on human fetal astrocytes
64. Smad6 inhibits signalling by the TGF-beta superfamily
65. Transforming growth factor-beta 1 and -beta 2 promote neurite sprouting and elongation of cultured rat hippocampal neurons
66. Transforming growth factor beta1 induces nuclear export of inhibitory Smad7
67. GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family
68. Transforming growth factor-beta 1 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures
69. Serine/threonine kinase receptors and ligands
70. Transforming growth factor-beta 1: A lesion-associated cytokine of the nervous system
71. The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms
72. Detection of ebaf, a novel human gene of the transforming growth factor beta superfamily: Association of gene expression with endometrial bleeding
73. Neurturin, a relative of glial-cell-line-derived neurotrophic factor
74. SMADs: Mediators and regulators of TGF-beta signaling
75. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase
76. Transforming growth factor-β promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridinium ion toxicity
77. Bovine chromaffin granules contain and release a transforming growth factor-β-like activity
78. Distinct modulatory actions of TGF-β and LIF on neurotrophin-mediated survival of developing sensory neurons
79. Neural functions of the transforming growth factors β
80. + toxicity
81. TGF-beta regulates the survival of ciliary ganglionic neurons synergistically with ciliary neurotrophic factor and neurotrophins
82. GDNF requires TGF-β for establishing its neurotrophic activity
83. Transforming growth factor type beta 1 modulates the effects of basic fibroblast growth factor on growth and phenotypic expression of rat astroblasts in vitro
84. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways
85. Transforming growth factor-beta: A general review
86. The specification of dorsal cell fates in the vertebrate central nervous system
87. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression
88. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
89. Transforming growth factor-β1 in the rat brain: Increase after injury and inhibition of astrocyte proliferation
90. Isolation and partial characterization of a M(r) 32,000 protein with inhibin activity from porcine follicular fluid
91. Human type II receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs
92. A human Mad protein acting as a BMP-regulated transcriptional activator
93. Ubiquitin-dependent degradation of TGF-beta-activated Smad2
94. Regulation of microglial activation by TGF-beta, IL-10, and CSF-1
95. Betaglycan presents ligand to the TGF beta signaling receptor
96. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling
97. Transforming growth factor-beta 2: Cdna cloning and sequence analysis
98. 1 is a potent survival factor for rat embryo motoneurons in culture
99. The transforming growth factor-beta family
100. Receptors for the TGF-beta family
101. TGF-beta signal transduction
102. Serine/threonine kinase receptors: Mediators of transforming growth factor beta family signals
103. The TGF-β family and its composite receptors
104. A structural superfamily of growth factors containing a cystine knot motif
105. A role for TGF-beta in oligodendrocyte differentiation
106. The non-synaptic expression of transforming growth factor-beta 2 is neurally regulated and varies between skeletal muscle fibre types
107. GDF-3 and GDF-9: Two new members of the transforming growth factor-β superfamily containing a novel pattern of cysteines
108. Bone morphogenetic proteins in the nervous system
109. Left-fight asymmetric expression of the TGF beta-family member lefty in mouse embryos
110. Persephin, a novel neurotrophic factor related to GDNF and neurturin
111. Autocrine and paracrine regulation of astrocyte function by transforming growth factor-β
112. Transforming growth factor production by chemically transformed cells
113. Identification of Smad7, a TGF-beta-inducible antagonist of TGF-beta signalling
114. Cytokines in context
115. Two forms of transforming growth factor-beta distinguished by multipotential haematopoietic progenitor cells
116. TGF-β suppression of IFN-γ-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-γ enhanced factor X expression
117. Modulation of inducible nitric oxide synthase expression in astroglial cells
118. In-situ hybridization analysis of TGF-β3 RNA expression during mouse development: Comparative studies with TGF-β1 and -β2
119. Immunohistochemical localization of TGF-β1, TGF-β2 and TGFβ3 in mouse embryo: Expression patterns suggest multiple roles during embryonic development
120. Differential expression of TGF-beta 1, 2 and 3 isotypes in Alzheimer's disease: A comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains
121. Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placenta cells
122. Specificity, diversity, and regulation in TGF-beta superfamily signaling
123. TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons
124. TGF-β in the central nervous system: Potential roles in ischemic injury and neurodegenerative diseases
125. Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila
126. Molecular signals for glial activation: Pro- and anti-inflammatory cytokines in the injured brain
127. Involvement of bone morphogenetic protein-4 and bone morphogenetic protein-7 in the differentiation of the adrenergic phenotype in developing sympathetic neurons
128. Control of C. elegans larval development by neuronal expression of a TGF-beta homolog
129. The transforming growth factor-βs
130. New class of transforming growth factors potentiated by epidermal growth factor: Isolation from nonneoplastic tissues
131. Purification and properties of a type beta transforming growth factor from bovine kidney
132. Floor plate and motor neuron induction by different concentrations of the amino-terminal cleavage product of sonic hedgehog autoproteolysis
133. In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin
134. Cloning and characterization of a human type II receptor for bone morphogenetic proteins
135. Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components
136. Transforming growth factors type beta 1 and beta 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-gamma and tumor necrosis factor-alpha
137. An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-β2
138. Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis
139. Expression of DSD-1-PG in primary neural and glial-derived cell line cultures, upregulation by TGF-beta, and implications for cell-substrate interactions of the glial cell line Oli-neu
140. Glial cell line-derived neurotrophic factor rescues target-deprived sympathetic spinal cord neurons hut requires transforming growth factor-beta as cofactor in vivo
141. Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster
142. Alternative neural crest cell fates are instructively promoted by TGFbeta superfamily members
143. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma in astrocytes
144. Stimulus-specific inhibition of intracellular adhesion molecule-1 gene expression by TGF-beta
145. Identification of a potent Xenopus mesodem-inducing factor as a homologue of activin A
146. The cystine-knot growth-factor superfamily
147. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro
148. GFRalpha-4, a new GDNF family receptor
149. Processed Vg1 protein is an axial mesoderm inducer in Xenopus
150. Localization of transforming growth factor beta in association with neuromuscular junctions in adult human muscle
151. Effects of transforming growth factor beta 1 on astroglial cells in culture
152. Characterization of a multicomponent receptor for GDNF
153. Functional receptor for GDNF encoded by the c-ret proto-oncogene
154. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor
155. The chromaffin cell: Paradigm in cell development and growth factor biology
156. Growth factors in chromaffin cells
157. Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system
158. Expression, localization, and function of transforming growth factor-βs in embryonic chick spinal cord, hindbrain, and dorsal root ganglia
159. Neurotrophic roles of GDNF and related factors
160. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid
161. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse
162. Transforming growth factor beta (TGF-β) in inflammation: A cause and a cure
163. A maternal mRNA localized to the vegetal hemisphere in Xenopus eggs codes for a growth factor related to TGF-beta
164. GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex
165. Formation and activation by phosphorylation of activin receptor complexes
166. Transforming growth factor-beta, but not ciliary neurotrophic factor, inhibits DNA synthesis of adrenal medullary cells in vitro
167. A Smad transcriptional corepressor
168. Novel regulators of bone formation: Molecular clones and activities
169. TGF beta signals through a heteromeric protein kinase receptor complex
170. Mechanism of activation of the TGF-beta receptor
171. Transforming growth factor-beta 1 (TGF-beta1)-mediated inhibition of glial cell proliferation and down-regulation of intercellular adhesion molecule-1 (ICAM-1) are interrupted by interferon-gamma (IFN-gamma)
172. Transforming growth factor-beta1 induces apoptosis of rat microglia without relation to bcl-2 oncoprotein expression
173. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta
174. Role of transforming growth factor-beta in long-term synaptic facilitation in Aplysia
175. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response
176. Nodal is a novel TGF-beta-like gene expressed in the mouse node during gastrulation